谷歌浏览器插件
订阅小程序
在清言上使用

Recombinantl-Asparaginase Production Usingpichia Pastoris(Mut(S)Strain): Establishment Of Conditions For Growth And Induction Phases

JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY(2021)

引用 9|浏览15
暂无评分
摘要
BACKGROUND l-asparaginase (ASNase), a biopharmaceutical enzyme used in the treatment of childhood lymphoid malignancies, is commercially produced fromEscherichia coliandErwinia chrysanthemi.However, it causes severe adverse effects due to allergenic prokaryotic epitopes on the protein surface. ASNase II fromSaccharomyces cerevisiaecan be a promising alternative source of this enzyme. In this study, conditions to produce ASNase fromS. cerevisiaeexpressed inPichia pastorishave been investigated in shake flasks and 3L-bioreactor. We evaluated if medium composition, concentration of carbon source (i.e. glycerol), growth time, concentration of inducer (i.e. methanol), temperature and initial pH influenced both biomass and ASNase expression. RESULTS Biomass of around 53 g L(-1)and ASNase volumetric activity of 710 U L(-1)were achieved using the buffered glycerol-complex medium (BMGY) containing 40 g L(-1)glycerol, with induction after 141 h using 3.0% (v/v) methanol, at 20 degrees C and initial pH 6.0. CONCLUSION The experiments performed in shake flasks were scalable to a 3L-bioreactor, suggesting that this bioprocess could be scaled-up for industrial production. (c) 2020 Society of Chemical Industry (SCI)
更多
查看译文
关键词
leukemia, l-asparaginase (ASNase), Saccharomyces cerevisiae, heterologous protein production, Pichia pastoris, biopharmaceutical
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要